Chimeric transcript discovery by paired-end transcriptome sequencing
Open accessThe DOI matches its Crossref record; 27 of the 29 references it cites were found in a registry or an index.
Abstract
Recurrent gene fusions are a prevalent class of mutations arising from the juxtaposition of 2 distinct regions, which can generate novel functional transcripts that could serve as valuable therapeutic targets in cancer. Therefore, we aim to establish a sensitive, high-throughput methodology to comprehensively catalog functional gene fusions in cancer by evaluating a paired-end transcriptome sequencing strategy. Not only did a paired-end approach provide a greater dynamic range in comparison with single read based approaches, but it clearly distinguished the high-level “driving” gene fusions, such as BCR-ABL1 and TMPRSS2-ERG , from potential lower level “passenger” gene fusions. Also, the comprehensiveness of a paired-end approach enabled the discovery of 12 previously undescribed gene fusions in 4 commonly used cell lines that eluded previous approaches. Using the paired-end transcriptome sequencing approach, we observed read-through mRNA chimeras, tissue-type restricted chimeras, converging transcripts, diverging transcripts, and overlapping mRNA transcripts. Last, we successfully used paired-end transcriptome sequencing to detect previously undescribed ETS gene fusions in prostate tumors. Together, this study establishes a highly specific and sensitive approach for accurately and comprehensively cataloguing chimeras within a sample using paired-end transcriptome sequencing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Over the last two years, with the further confirmation that the relatively short reads can be effectively assembled [15], especially with the great advantage of paired-end sequencing [54], the Illumina transcriptome or whole genome de novo sequencing and assembly have been successfully used for model [12,16,55-58]and non-model organisms [25-27,59].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mapping and quantifying mammalian transcriptomes by RNA-Seq
Mortazavi, A., Williams, B. A., McCue, K., Schaeffer, L., & Wold, B. (2008) · Nature Methods · doi:10.1038/nmeth.1226 · Cited by 13,696 · cited 1×
“Although current RNA sequencing (RNA-Seq) studies have been using 36-nt single reads (16, 17), we increased the likelihood of spanning a fusion junction by generating 100-nt long single reads using the Illumina Genome Analyzer II.”
MethodIdentification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer
Soda, M., Choi, Y. L., Enomoto, M., Takada, S., Yamashita, Y., Ishikawa, S., Fujiwara, S.-I., Watanabe, H., Kurashina, K., Hatanaka, H., et al. (2007) · Nature · doi:10.1038/nature05945 · Cited by 5,439 · cited 1×
“However, the recent discovery of a recurrent gene fusion, TMPRSS2-ERG, in a majority of prostate cancers (5, 6), and EML4-ALK in non-small-cell lung cancer (NSCLC) (7), has expanded the realm of gene fusions as an oncogenic mechanism in common solid cancers.”
BackgroundRecurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
Tomlins, S. A., Rhodes, D. R., Perner, S., Dhanasekaran, S. M., Mehra, R., Sun, X.-W., Varambally, S., Cao, X., Tchinda, J., Kuefer, R., et al. (2005) · Science · doi:10.1126/science.1117679 · Cited by 3,846
Self-citationFive-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia
Druker, B. J., Guilhot, F., O'Brien, S. G., Gathmann, I., Kantarjian, H., Gattermann, N., Deininger, M. W. N., Silver, R. T., Goldman, J. M., Stone, R. M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062867 · Cited by 3,488
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
Neve, R. M., Chin, K., Fridlyand, J., Yeh, J., Baehner, F. L., Fevr, T., Clark, L., Bayani, N., Coppe, J.-P., Tong, F., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.008 · Cited by 3,188
A census of human cancer genes
Futreal, P. A., Coin, L., Marshall, M., Down, T., Hubbard, T., Wooster, R., Rahman, N., & Stratton, M. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1299 · Cited by 3,184 · cited 1×
“O of the most common classes of genetic alterations is gene fusions, resulting from chromosomal rearrangements (1).”
BackgroundEffects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells
Druker, B. J., Tamura, S., Buchdunger, E., Ohno, S., Segal, G. M., Fanning, S., Zimmermann, J., & Lydon, N. B. (1996) · Nature Medicine · doi:10.1038/nm0596-561 · Cited by 2,967
RNA-seq: An assessment of technical reproducibility and comparison with gene expression arrays
Marioni, J. C., Mason, C. E., Mane, S. M., Stephens, M., & Gilad, Y. (2008) · Genome Research · doi:10.1101/gr.079558.108 · Cited by 2,771
Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia
Kantarjian, H., Sawyers, C., Hochhaus, A., Guilhot, F., Schiffer, C., Gambacorti-Passerini, C., Niederwieser, D., Resta, D., Capdeville, R., Zoellner, U., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011573 · Cited by 2,019
Fused transcript of abl and bcr genes in chronic myelogenous leukaemia
Shtivelman, E., Lifshitz, B., Gale, R. P., & Canaani, E. (1985) · Nature · doi:10.1038/315550a0 · Cited by 1,611
Cited by
Items 101–200 of 383
Abate, F., Zairis, S., Ficarra, E., Acquaviva, A., Wiggins, C. H., Frattini, V., Lasorella, A., Iavarone, A., Inghirami, G. G., & Rabadán, R. (2014) · BMC Systems Biology · doi:10.1186/s12918-014-0097-z · Cited by 77
Detecting structural variations in the human genome using next generation sequencing
Xi, R., Kim, T., & Park, P. J. (2010) · Briefings in Functional Genomics · doi:10.1093/bfgp/elq025 · Cited by 76
Linkers: A synergistic way for the synthesis of chimeric proteins
Patel, D. K., Vettiatil, D., Patel, D., & Dave, G. (2021) · Protein Expression and Purification · doi:10.1016/j.pep.2021.106012 · Cited by 73
Routh, A. L., Head, S. R., Ordoukhanian, P. T., & Johnson, J. E. (2015) · Journal of Molecular Biology · doi:10.1016/j.jmb.2015.06.011 · Cited by 73
InFusion: Advancing Discovery of Fusion Genes and Chimeric Transcripts from Deep RNA-Sequencing Data
Okonechnikov, K., Imai‐Matsushima, A., Paul, L., Seitz, A., Meyer, T. F., & García-Alcalde, F. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167417 · Cited by 73
TCF12 is mutated in anaplastic oligodendroglioma
Labrèche, K., Simeonova, I., Kamoun, A., Gleize, V., Chubb, D., Letouzé, É., Riazalhosseini, Y., Dobbins, S. E., Elarouci, N., Ducray, F., et al. (2015) · Nature Communications · doi:10.1038/ncomms8207 · Cited by 71
RNA-Seq and its applications: a new technology for transcriptomics
Qi, Y., Liu, Y., & Wei-heng, R. (2011) · Hereditas (Beijing) · doi:10.3724/sp.j.1005.2011.01191 · Cited by 72
Sensitive gene fusion detection using ambiguously mapping RNA-Seq read pairs
Kinsella, M., Harismendy, O., Nakano, M., Frazer, K. A., & Bafna, V. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr085 · Cited by 69
ChiTaRS: a database of human, mouse and fruit fly chimeric transcripts and RNA-sequencing data
Frenkel‐Morgenstern, M., Gorohovski, A., Lacroix, V., Rogers, M. F., Ibáñez, K., Boullosa, C., Andrés‐León, E., Ben‐Hur, A., & Valencia, A. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1041 · Cited by 66
FusionFinder: A Software Tool to Identify Expressed Gene Fusion Candidates from RNA-Seq Data
Francis, R. W., Thompson-Wicking, K., Carter, K. W., Anderson, D. R., Kees, U. R., & Beesley, A. H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039987 · Cited by 64
Is an observed non-co-linear RNA product spliced intrans, incisor justin vitro?
Yu, C., Liu, H.-J., Hung, L.-Y., Kuo, H., & Chuang, T. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku643 · Cited by 63
The Genomics of Prostate Cancer: emerging understanding with technologic advances
Rubin, M. A., & Demichelis, F. (2018) · Modern Pathology · doi:10.1038/modpathol.2017.166 · Cited by 63
Androgen receptor-driven chromatin looping in prostate cancer
Wu, D., Zhang, C., Shen, Y., Nephew, K. P., & Wang, Q. (2011) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2011.07.006 · Cited by 62
RNA Transcription and Splicing Errors as a Source of Cancer Frameshift Neoantigens for Vaccines
Shen, L., Zhang, J., Lee, H., Batista, M. T., & Johnston, S. A. (2019) · Scientific Reports · doi:10.1038/s41598-019-50738-4 · Cited by 62
A Comparison of Single Molecule and Amplification Based Sequencing of Cancer Transcriptomes
Sam, L. T., Lipson, D., Raz, T., Cao, X., Thompson, J., Milos, P. M., Robinson, D., Chinnaiyan, A. M., Kumar-Sinha, C., & Maher, C. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017305 · Cited by 54
Self-citationESRRA-C11orf20 Is a Recurrent Gene Fusion in Serous Ovarian Carcinoma
Salzman, J., Marinelli, R. J., Wang, P., Green, A. E., Nielsen, J. S., Nelson, B. H., Drescher, C. W., & Brown, P. O. (2011) · PLoS Biology · doi:10.1371/journal.pbio.1001156 · Cited by 61
A novel approach to identify driver genes involved in androgen-independent prostate cancer
Schinke, E. N., Bii, V. M., Nalla, A. K., Rae, D. T., Tedrick, L., Meadows, G. G., & Trobridge, G. D. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-120 · Cited by 59
Fernandez-Cuesta, L., Sun, R., Menon, R., George, J., Lorenz, S., Meza-Zepeda, L. A., Peifer, M., Plenker, D., Heuckmann, J. M., Leenders, F., et al. (2015) · Genome Biology · doi:10.1186/s13059-014-0558-0 · Cited by 56
CINSARC signature as a prognostic marker for clinical outcome in sarcomas and beyond
Chibon, F., Lesluyes, T., Valentin, T., & Guellec, S. L. (2018) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22703 · Cited by 59
Does massively parallel DNA resequencing signify the end of histopathology as we know it?
Aparicio, S. A. J. R., & Huntsman, D. D. (2009) · The Journal of Pathology · doi:10.1002/path.2636 · Cited by 58
Gorohovski, A., Tagore, S., Palande, V., Malka, A., Shay, D. R., & Frenkel‐Morgenstern, M. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw1127 · Cited by 57
Chromosomal instability and transcriptome dynamics in cancer
Stevens, J. B., Horne, S. D., Abdallah, B. Y., Ye, C. J., & Heng, H. H. (2013) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9428-6 · Cited by 56
MacConaill, L. E., Van Hummelen, P., Meyerson, M., & Hahn, W. C. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0110 · Cited by 54
cDNA Hybrid Capture Improves Transcriptome Analysis on Low-Input and Archived Samples
Cabanski, C. R., Magrini, V., Griffith, M., Griffith, O. L., McGrath, S., Zhang, J., Walker, J., Ly, A., Demeter, R., Fulton, R. S., et al. (2014) · The Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2014.03.004 · Cited by 46
Self-citationGenomic profiling of high-risk acute lymphoblastic leukemia
Collins-Underwood, J. R., & Mullighan, C. G. (2010) · Leukemia · doi:10.1038/leu.2010.177 · Cited by 53
McPherson, A., Wu, C., Hajirasouliha, I., Hormozdiari, F., Hach, F., Lapuk, A., Volik, S., Shah, S., Collins, C., & Sahinalp, S. C. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr184 · Cited by 45
Poly‐gene fusion transcripts and chromothripsis in prostate cancer
Wu, C., Wyatt, A. W., McPherson, A., Lin, D., McConeghy, B. J., Mo, F., Shukin, R., Lapuk, A. V., M. Jones, S. J., Zhao, Y., et al. (2012) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.21999 · Cited by 51
Application of second-generation sequencing to cancer genomics
Robison, K. E. (2010) · Briefings in Bioinformatics · doi:10.1093/bib/bbq013 · Cited by 51
Evolving techniques for gene fusion detection in soft tissue tumours
Mertens, F., & Tayebwa, J. (2013) · Histopathology · doi:10.1111/his.12272 · Cited by 50
Disruption of NCOA2 by recurrent fusion with LACTB2 in colorectal cancer
Yu, J. Q., Wu, W. K. K., Liang, Q., Zhang, N., He, J., Li, X., Zhang, X., Xu, L., Chan, M. T. V., Ng, S. S. M., et al. (2015) · Oncogene · doi:10.1038/onc.2015.72 · Cited by 50
Self-citationRNA-Seq Mapping and Detection of Gene Fusions with a Suffix Array Algorithm
Sakarya, O., Breu, H., Radovich, M., Chen, Y., Wang, Y., Bárbácioru, C., Utiramerur, S., Whitley, P., Brockman, J. P., Vatta, P., et al. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002464 · Cited by 49
Recurrent reciprocal RNA chimera involving YPEL5 and PPP1CB in chronic lymphocytic leukemia
Velusamy, T., Palanisamy, N., Sundaram, S. K., Sahasrabuddhe, A. A., Maher, C. A., Robinson, D. R., Bahler, D. W., Cornell, T. T., Wilson, T. E., Lim, M. S., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1214326110 · Cited by 49
Self-citationHa, K., Lalonde, E., Li, L., Cavallone, L., Natrajan, R., Lambros, M. B. K., Mitsopoulos, C., Hakas, J., Kozarewa, I., Fenwick, K., et al. (2011) · BMC Medical Genomics · doi:10.1186/1755-8794-4-75 · Cited by 48
Novel 5′ Fusion Partners of ETV1 and ETV4 in Prostate Cancer
Barros-Silva, J. D., Paulo, P., Bakken, A. C., Cerveira, N., Løvf, M., Henrique, R., Jerónimo, C., Lothe, R. A., Skotheim, R. I., & Teixeira, M. R. (2013) · Neoplasia · doi:10.1593/neo.13232 · Cited by 48
Recurrent cis-SAGe chimeric RNA, D2HGDH-GAL3ST2, in prostate cancer
Qin, F., Song, Z., Chang, M., Song, Y., Frierson, H. F., & Li, H. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.06.013 · Cited by 49
A time-invariant principle of genome evolution
De, S., & Babu, M. M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914454107 · Cited by 47
Next-generation sequencing applied to molecular diagnostics
Natrajan, R., & Reis-Filho, J. S. (2011) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.11.18 · Cited by 48
Outlier Kinase Expression by RNA Sequencing as Targets for Precision Therapy
Kothari, V., Wei, I. H., Shankar, S., Sundaram, S. K., Wang, L., Ma, L. W., Vats, P., Grasso, C. S., Robinson, D. R., Wu, Y.-M., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0336 · Cited by 47
Self-citationAlternative applications for distinct RNA sequencing strategies
Han, L., Vickers, K. C., Samuels, D. C., & Guo, Y. P. (2014) · Briefings in Bioinformatics · doi:10.1093/bib/bbu032 · Cited by 45
Abate, F., Acquaviva, A., Paciello, G., Foti, C., Ficarra, E., Ferrarini, A., Delledonne, M., Iacobucci, I., Soverini, S., Martinelli, G., et al. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts334 · Cited by 45
Pflueger, D., Sboner, A., Storz, M., Roth, J., Compérat, É., Bruder, E., Rubin, M. A., Schraml, P., & Moch, H. (2013) · Neoplasia · doi:10.1593/neo.131544 · Cited by 44
Li, N., Zheng, J., Li, H., Deng, J., Hu, M., Wu, H., Li, W., Li, F., Lan, X., Lü, J., et al. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu201 · Cited by 44
Clinical cancer genomics: how soon is now?
Taylor, B. S., & Ladanyi, M. (2010) · The Journal of Pathology · doi:10.1002/path.2794 · Cited by 43
FuseFISH: Robust Detection of Transcribed Gene Fusions in Single Cells
Semrau, S., Crosetto, N., Bienko, M., Boni, M., BERNASCONI, P. P., Chiarle, R., & van Oudenaarden, A. (2014) · Cell Reports · doi:10.1016/j.celrep.2013.12.002 · Cited by 45
ChimPipe: accurate detection of fusion genes and transcription-induced chimeras from RNA-seq data
Rodríguez–Martín, B., Palumbo, E., Marco‐Sola, S., Griebel, T., Ribeca, P., Alonso, G., Rastrojo, A., Aguado, B., Guigó, R., & Djebali, S. (2017) · BMC Genomics · doi:10.1186/s12864-016-3404-9 · Cited by 43
The DNA damage response: The omics era and its impact
Derks, K., Hoeijmakers, J. H. J., & Pothof, J. (2014) · DNA repair · doi:10.1016/j.dnarep.2014.03.008 · Cited by 43
Fusion FISH Imaging: Single-Molecule Detection of Gene Fusion Transcripts In Situ
Markey, F. B., Ruezinsky, W., Tyagi, S., & Batish, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093488 · Cited by 43
Peng, Z., Yuan, C., Zellmer, L., Liu, S., Xu, N., & Liao, D. J. (2015) · Journal of Cancer · doi:10.7150/jca.11997 · Cited by 42
Microseminoprotein-Beta Expression in Different Stages of Prostate Cancer
Sjöblom, L., Saramäki, O. R., Annala, M., Leinonen, K. A., Nättinen, J. E., Tolonen, T. T., Wahlfors, T., Nykter, M., Bova, G. S., Schleutker, J., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150241 · Cited by 42
Novel domain combinations in proteins encoded by chimeric transcripts
Frenkel‐Morgenstern, M., & Valencia, A. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts216 · Cited by 42
Palande, V., Siegal, T., Detroja, R., Gorohovski, A., Glaß, R., Flueh, C., Kanner, A. A., Laviv, Y., Harnof, S., Levy‐Barda, A., et al. (2021) · Molecular Oncology · doi:10.1002/1878-0261.13157 · Cited by 41
Chmielecki, J., Peifer, M., Jia, P., Socci, N. D., Hutchinson, K. E., Viale, A. J., Zhao, Z., Thomas, R. K., & Pao, W. J. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq579 · Cited by 41
The Genomic Landscape of Prostate Cancer
Spans, L., Clinckemalie, L., Helsen, C., Vanderschueren, D., Boonen, S., Lerut, E., Joniau, S., & Claessens, F. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140610822 · Cited by 40
NGS catalog: A database of next generation sequencing studies in humans
Xia, J., Wang, Q., Jia, P., Wang, B., Pao, W., & Zhao, Z. (2012) · Human Mutation · doi:10.1002/humu.22096 · Cited by 39
Zhang, Y., Liang, Y., Randesi, M., Yuferov, V. P., Zhao, C., & Kreek, M. J. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.07.032 · Cited by 40
Riccardo, F., Arigoni, M., Buson, G., Zago, E. D., Iezzi, M., Longo, D. L., Carrara, M., Fiore, A., Nuzzo, S., Bicciato, S., et al. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-s3-s1 · Cited by 40
FusionAnalyser: a new graphical, event-driven tool for fusion rearrangements discovery
Piazza, R., Pirola, A., Spinelli, R., Valletta, S., Redaelli, S., Magistroni, V., & Gambacorti-Passerini, C. B. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks394 · Cited by 39
Savalas, L. R. T., Gasnier, B., Daμμe, M., Lübke, T., Wrocklage, C., Debacker, C., Jézégou, A., Reinheckel, T., Hasilík, A., Säftig, P., et al. (2011) · Biochemical Journal · doi:10.1042/bj20110166 · Cited by 39
The CINSARC signature as a prognostic marker for clinical outcome in multiple neoplasms
Lesluyes, T., Delespaul, L., Coindre, J., & Chibon, F. (2017) · Scientific Reports · doi:10.1038/s41598-017-05726-x · Cited by 40
Next generation sequencing approach for detecting 491 fusion genes from human cancer
Urakami, K., Shimoda, Y., Ohshima, K., Nagashima, T., Serizawa, M., TANABE, T., SAITO, J., Tamiko, U. S. U. I., Watanabe, Y., Naruoka, A., et al. (2016) · Biomedical Research · doi:10.2220/biomedres.37.51 · Cited by 38
Prevention, diagnosis and treatment of high‐throughput sequencing data pathologies
Zhou, X., & Rokas, A. (2014) · Molecular Ecology · doi:10.1111/mec.12680 · Cited by 38
RNA-Seq Based De Novo Transcriptome Assembly and Gene Discovery of Cistanche deserticola Fleshy Stem
Li, Y., Wang, X., Chen, T., Yao, F., Li, C., Tang, Q., Sun, M., Sun, G., Hu, S., Yu, J. M., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125722 · Cited by 37
Self-citationThe evolving landscape of prostate cancer somatic mutations
Cotter, K. A., & Rubin, M. A. (2022) · The Prostate · doi:10.1002/pros.24353 · Cited by 37
Implementing precision cancer medicine in the genomic era
Chen, H., Bonneville, R., & Roychowdhury, S. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.05.009 · Cited by 37
Frenkel‐Morgenstern, M., Gorohovski, A., Tagore, S., Sekar, V., Vázquez, M., & Valencia, A. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx423 · Cited by 36
Frenkel‐Morgenstern, M., Gorohovski, A., Vučenović, D., Maestre, L., & Valencia, A. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku1199 · Cited by 34
Ovarian Cancer Biomarker Discovery Based on Genomic Approaches
Lee, J., Kim, H. S., Suh, D. H., Kim, M.-K., Chung, H. H., & Song, Y. S. (2013) · Journal of Cancer Prevention · doi:10.15430/jcp.2013.18.4.298 · Cited by 34
Zhou, J. X., Yang, X.-Y., Ning, S., Wang, L., Wang, K., Zhang, Y., Yuan, F., Li, F., Zhuo, D. D., Tang, L., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.16385 · Cited by 34
FusionQ: a novel approach for gene fusion detection and quantification from paired-end RNA-Seq
Liu, C., Ma, J., Chang, C.-C., & Zhou, X. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-193 · Cited by 33
Genomic rearrangements in prostate cancer
Barbieri, C. E., & Rubin, M. A. (2014) · Current Opinion in Urology · doi:10.1097/mou.0000000000000129 · Cited by 33
Li, Y., Heavican, T. B., Vellichirammal, N. N., Iqbal, J., & Guda, C. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx315 · Cited by 33
RNA-seq Using Next Generation Sequencing
Corney, D. C. (2013) · Materials and Methods · doi:10.13070/mm.en.3.203 · Cited by 34
Ma, C. X., Suman, V. J., Sanati, S., Vij, K. R., Anurag, M., Leitch, A. M., Unzeitig, G. W., Hoog, J., Fernández-Martínez, A., Fan, C., et al. (2024) · JAMA Oncology · doi:10.1001/jamaoncol.2023.6038 · Cited by 32
Next-Generation Sequencing of Cancer Genomes: Back to the Future
Walter, M. J., Graubert, T. A., DiPersio, J. F., Mardis, E. R., Wilson, R. K., & Ley, T. J. (2009) · Personalized Medicine · doi:10.2217/pme.09.52 · Cited by 31
Perini, C. R., Tabuloc, C. A., Chiu, J. C., Zalom, F. G., Stacke, R. F., Bernardi, O., Nelson, D. R., & Guedes, J. V. C. (2020) · Journal of Economic Entomology · doi:10.1093/jee/toaa233 · Cited by 31
Chromosomal Aberrations in Solid Tumors
Chinnaiyan, A. M., & Palanisamy, N. (2010) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385071-3.00004-6 · Cited by 33
Self-citationIyer, M. K., & Chinnaiyan, A. M. (2011) · Nature Biotechnology · doi:10.1038/nbt.1915 · Cited by 32
Self-citationSOAPfusion: a robust and effective computational fusion discovery tool for RNA-seq reads
Wu, J., Zhang, W., Huang, S., He, Z., Cheng, Y., Wang, J., Lam, T., Peng, Z., & Yiu, S. (2013) · Bioinformatics · doi:10.1093/bioinformatics/btt522 · Cited by 31
Recurrent Gene Fusions in Prostate Cancer: Their Clinical Implications and Uses
Hessels, D., & Schalken, J. A. (2013) · Current Urology Reports · doi:10.1007/s11934-013-0321-1 · Cited by 30
Gao, J., Luo, M., Zhu, Y., He, Y., Wang, Q., & Zhang, C. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.02.066 · Cited by 30
A probabilistic framework for aligning paired-end RNA-seq data
Hu, Y., Wang, K., He, X., Chiang, D. Y., Prins, J. F., & Liu, J. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq336 · Cited by 30
ETS rearrangements in prostate cancer
Rubin, M. A. (2012) · Asian Journal of Andrology · doi:10.1038/aja.2011.145 · Cited by 30
Detection of DNA fusion junctions for BCR-ABL translocations by Anchored ChromPET
Shibata, Y., Malhotra, A., & Dutta, A. (2010) · Genome Medicine · doi:10.1186/gm191 · Cited by 29
Liu, Z., Yang, F., Zhao, M., Ma, L., Li, H., Xie, Y., Nai, R., Che, T., Su, R., Zhang, Y., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-31986-2 · Cited by 27
Comparative study of bioinformatic tools for the identification of chimeric RNAs from RNA Sequencing
Singh, S., & Li, H. (2021) · RNA Biology · doi:10.1080/15476286.2021.1940047 · Cited by 26
Chmielecki, J., Peifer, M., Viale, A. J., Hutchinson, K. E., Giltnane, J. M., Socci, N. D., Hollis, C. J., Dean, R. S., Yenamandra, A. K., Jagasia, M., et al. (2011) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20930 · Cited by 26
The Genomics of Prostate Cancer: A Historic Perspective
Rubin, M. A., & Demichelis, F. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a034942 · Cited by 26
Next generation analysis of breast cancer genomes for precision medicine
Previati, M., Manfrini, M., Galasso, M., Zerbinati, C., Palatini, J., Gasparini, P., & Volinia, S. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.07.018 · Cited by 25
Molecular Logic Underlying Chromosomal Translocations, Random or Non-Random?
Lin, C., Yang, L., & Rosenfeld, M. G. (2012) · Advances in cancer research · doi:10.1016/b978-0-12-394280-7.00015-4 · Cited by 25
Cancer genomics identifies determinants of tumor biology
Mardis, E. R. (2010) · Genome biology · doi:10.1186/gb-2010-11-5-211 · Cited by 25
He, J., Sun, X., Shi, T., Schepmoes, A., Fillmore, T., Petyuk, V., Xie, F., Zhao, R., Gritsenko, M. A., Yang, F., et al. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.02.004 · Cited by 25
Self-citationDNA Amplifications in Breast Cancer: Genotypic–Phenotypic Correlations
Shiu, K., Natrajan, R., Geyer, F. C., Ashworth, A., & Reis-Filho, J. S. (2010) · Future Oncology · doi:10.2217/fon.10.56 · Cited by 24
Spatial Proximity and Similarity of the Epigenetic State of Genome Domains
Khrameeva, E. E., Mironov, A. A., Fedonin, G. G., Khaitovich, P., & Gelfand, M. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033947 · Cited by 24
NKL homeobox gene activities in normal and malignant myeloid cells
Nagel, S., Scherr, M., MacLeod, R. A. F., Pommerenke, C., Koeppel, M., Meyer, C., Kaufmann, M., Dallmann, I., & Drexler, H. G. (2019) · PLoS ONE · doi:10.1371/journal.pone.0226212 · Cited by 24
Genomic tools in acute myeloid leukemia: From the bench to the bedside
White, B. S., & DiPersio, J. F. (2014) · Cancer · doi:10.1002/cncr.28552 · Cited by 23
Kumar, R. R., Goswami, S., Shamim, M., Dubey, K., Singh, K., Singh, S., Kala, Y. K., Niraj, R. R. K., Sakhrey, A., Singh, G. P., et al. (2017) · Functional & Integrative Genomics · doi:10.1007/s10142-017-0560-1 · Cited by 23
Clinical Application of Gene Expression Profiling in Breast Cancer
Sparano, J. A., Fazzari, M. J., & Kenny, P. A. (2010) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2010.03.008 · Cited by 23
De novo transcriptome analysis of mulberry (Morus L.) under drought stress using RNA-Seq technology
Wang, H., Tong, W., Feng, L., Jiao, Q., Li, L., Fang, R., & Zhao, W. (2014) · Russian Journal of Bioorganic Chemistry · doi:10.1134/s1068162014040037 · Cited by 23
Jang, J.-E., Kim, H., Han, S., Jang, H. S., Lee, S.-H., Song, S., Bang, D., & Kim, T. (2018) · Cancer Research and Treatment · doi:10.4143/crt.2018.103 · Cited by 23
Singh, B. K., Mishra, D. C., Yadav, S., Ambawat, S., Malhotra, E. V., Tribhuvan, K. U., Kumar, A., Kumar, S., Kumar, S., Chaturvedi, K. K., et al. (2016) · Journal of Plant Biochemistry and Biotechnology · doi:10.1007/s13562-016-0353-y · Cited by 22
Metadata
- Authors
- Maher, C. A., Palanisamy, N., Brenner, J. C., Cao, X., Kalyana-Sundaram, S., Luo, S., Khrebtukova, I., Barrette, T. R., Grasso, C., Yu, J., Lonigro, R. J., Schroth, G., Kumar-Sinha, C., & Chinnaiyan, A. M.
- Affiliations
- Michigan Center for Translational Pathology (US)
- University of Michigan (US)
- Michigan Center for Translational Pathology, Ann Arbor, MI 48109;
- Illumina (United States) (US)
- Howard Hughes Medical Institute (US)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2009-07-28
- Volume
- 106
- Issue
- 30
- Pages
- 12353-12358
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2708976
- OpenAlex
- W2169810552
- Cited by
- 339
- References
- 29
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 3 · 2023: 7 · 2022: 6 · 2021: 7 · 2020: 15 · 2019: 13 · 2018: 11 · 2017: 24 · 2016: 21 · 2015: 28 · 2014: 27 · 2013: 41 · 2012: 49
- FWCI
- 17.43
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institute on Drug Abuse (U54DA021519)
- National Cancer Institute (P50-CA-69568, R01CA132874, U01CA111275, K99CA129565, P50CA069568)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Phylogenetic Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Keywords
- gene fusion, fusion transcripts, BCR-ABL1, TMPRSS2-ERG fusion, ETS gene fusions, prostate cancer, cancer mutations
- MeSH terms
- Base Sequence, Humans, Male, Molecular Sequence Data, Neoplasms, Prostatic Neoplasms, RNA, Messenger, Transcription, Genetic, Oncogene Proteins, Fusion, Gene Expression Regulation, Neoplastic, Fusion Proteins, bcr-abl, Sequence Analysis, DNA, K562 Cells, Reverse Transcriptase Polymerase Chain Reaction, Gene Expression Profiling, Cell Line, Tumor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.